Deepverge PLC Notice of Final Results and Annual Report
13 June 2022 - 4:00PM
RNS Non-Regulatory
TIDMDVRG
Deepverge PLC
13 June 2022
13 June 2022
DeepVerge PLC
("DeepVerge" or "the Company")
Notice of Final Results and Annual Report
Skin Trust Club continues to expand with accelerated
momentum
DeepVerge (LSE:DVRG.L) today announces that it will publish its
Final Results and Annual Report for the year ended 31 December 2021
on 23 June 2022.
Gerard Brandon, CEO of DeepVerge, comments:
"As we prepare to publish our Annual Report demonstrating growth
across the whole business, Skin Trust Club has rapidly become a key
segment of the Labskin Division. We continue to see accelerated
growth with the number of repeat customers; countries in which we
are now operating; additional skincare brands on our marketplace
app plus numerous high-profile companies from different industry
sectors wanting to work with us. In a $145 billion skincare market,
Skin Trust Club is the new era of personalised skin care."
Skin Trust Club:
Having recently been awarded the Best New Disruptor Brand 2022
from the Pure Beauty Global Awards, and concluding a study showing
more than 63% of people get their skin type wrong, Skin Trust Club
is helping thousands of members get it right.
Skin Trust Club has the largest skin microbiome database in the
world and the range of applications is expanding:
-- Skin Trust Club B2C: Member home test kit.
-- Skin Trust Club B2B: Test kit sales and data intelligence to
our retail partners through an affiliate programme.
-- Skin Trust Club B2B: Affiliate programme sales.
-- Skin Trust Medical B2B: Home test kit referral services for
dermatology professionals in development.
-- Skin Trust Club has over 20,000 members with more than 50,000 visits per month.
-- The marketplace service is expanding rapidly with more than 300 products now available.
-- Intense interest from the US market resulted in unprecedented
demand for Skin Trust Club test kits.
For further information please contact:
+44 (0) 7340 055
DeepVerge plc Gerard Brandon, CEO 648
SPARK Advisory Partners Limited Neil Baldwin/Andrew +44 (0) 113 370
(Nominated Adviser) Emmott 8974
Turner Pope Investments (TPI) Andy Thacker/James +44 (0) 20 3657
Limited (Broker) Pope 0050
About DeepVerge plc (www.deepverge.com)
DeepVerge is an environmental and life science group of
companies that develops and applies AI and IoT technology to
analytical instruments for the analysis and identification of
bacteria, virus and toxins. Utilising artificial intelligent data
analytics to scientifically prove the impact of skincare product
claims on skin microbiome for most of the top 20 global cosmetic
company clients and remotely detect and identify in real-time,
dangerous pathogens in wastewater treatment plants, drinking water,
rivers, lakes and reservoirs.
Skin Trust Club
Skin Trust Club incorporates an artificial intelligence Skincare
App and Home Test Kit that provide simple, at-home skin microbiome
testing for personalised skincare and skin health tracking. The
self-administered skin swab is a remote trial and allows the
participant to conduct each stage of the trial without interaction.
Skin Trust Club's DNA Test generates a report that consumers can
use to manage their custom skincare regime. Analysis of skin
attributes provides information to create hundreds of different
product combinations to suit a person's unique skin microbiome.
Labskin (Life Science Division)
Labskin is a 3D human skin equivalent test platform that
scientifically proves the impact of skincare product claims in
healthcare, life sciences, skin microbiome clinical trials,
pharmaceutical and cosmetics industries. Labskin have been
pioneering the development of a laboratory grown human skin
platform for 15 years and is the only commercially available
lab-grown full thickness human skin model that naturally mimics the
skins' microbiome. Labskin's virtual clinical trials with remote
collection of human volunteers' skin microbiome provides a solution
for the collection of volunteer microbiomes to allow for
lab-controlled trials of advanced skin models and human
microbiomes. As the data bank of remote volunteers grows, the
higher the accuracy and increased reliability of virtual product
testing that can be provided to clients, eliminating early human
trial and error testing and resulting in a faster time to market.
The Labskin test platform and protocols help clients maintain an
optimum real-world environment, when testing their new ingredients
and existing products, that shows the positive or negative impact
on skin's natural microflora.
About Reach announcements
Reach is an investor communication service aimed at assisting
listed and unlisted (including AIM quoted) companies to distribute
media only / non-regulatory news releases such as marketing
messages, corporate and product information into the public domain.
An RNS Regulatory announcement is required to be notified under the
AIM Rules for Companies.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAFLFIRRTIILIF
(END) Dow Jones Newswires
June 13, 2022 02:00 ET (06:00 GMT)
Integumen (LSE:SKIN)
Historical Stock Chart
From Apr 2024 to May 2024
Integumen (LSE:SKIN)
Historical Stock Chart
From May 2023 to May 2024